DrugSupplement
Glycyrrhizic Acid clinical trials
Also written Glycyrrhizin.
Keep track of what changes. Save the Glycyrrhizic Acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Other names
Combined with it in one product
Studies by the year they started
10 studies that test it; most in 2010 (1)
| Year | Studies |
|---|---|
| 2010 | 1 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 5
Catalysis SL (4) · Mansoura University (1) · Tongji Hospital (1) · Al-Azhar University (1) · University of Illinois at Chicago (1) · Umeå University (1) · Cttq (1)
Often tested with
Tested in the same studies.
Viusid (2) · Grape Seed Extract (1) · Ocoxin (1) · Magnesium isoglycyrrhizinate (1)
Studies
Open first, then newest update. How each study uses Glycyrrhizic Acid is read from its arms, and is right about nine times in ten.
Testing it · 10
- Study on the Effect of Oral Diammonium Glycyrrhizinate in Attenuating Toxicity and Enhancing Efficacy of CAR-T Cell TherapyNot yet recruitingPhase 2/3Tongji HospitalNCT07616271Written as Diammonium glycyrrhizinate Capsules
- GU-01: Glycyrrhizin in Prostate CancerRecruitingPhase 2University of Illinois at ChicagoNCT06378346Written as Glycyrrhizin - 75 mg
- Revascularization of Young Immature Permenant Teeth Using Different Types of Intra Canal MedicationNot yet recruitingNot applicableAl-Azhar UniversityNCT07236567Written as Glycyrrhizin
- Evaluation Glizigen® and Ocoxin®-Viusid® in High-grade Cervical Intraepithelial LesionsRecruitingPhase 2Catalysis SLNCT03549273Written as Glizigen® + Ocoxin-Viusid®
- Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)RecruitingPhase 4Catalysis SLNCT05916911Written as Glizigen
- Molecular Analysis of Intracanal Microbes After Chemomechanical Procedure and Root Canal Medication: A Randomized Controlled TrialCompletedPhase 1Mansoura UniversityNCT06291623Written as Glycyrrhizin
- Liquorice and Salivary CortisolStatus unknownNot applicableUmeå UniversityNCT04045015Written as Liqourice
- Efficacy of VIUSID® Plus GLIZIGEN® in Patients With Papilloma Virus EsophagealCompletedPhase 2Catalysis SLNCT03584308Written as Glizigen®
- Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownPhase 4CttqNCT03349008Written as Diammonium Glycyrrhizinate
- Glizigen-Viudid-External Anogenital Warts in Children and AdolescentsCompletedPhase 3Catalysis SLNCT01111344Written as Glizigen + Viusid
As the comparator · 1 — what is tested is compared with Glycyrrhizic Acid
Codes
What other systems call Glycyrrhizic Acid · ClinicalTrials.gg INT008711
- MeSH (NLM) D019695Glycyrrhizic AcidConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 6FO62043WKGLYCYRRHIZINConfirmed FDA, NLM
- RxNorm 26143One source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D019695 | Glycyrrhizic Acid | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 6FO62043WK | GLYCYRRHIZIN | Confirmed FDA, NLM |
| RxNorm | 26143 | — | One source FDA |
Also registered as diammonium glycyrrhizinate (UNII A9ZZD585U6) and glycyrrhizinate dipotassium (UNII CA2Y0FE3FX · RxNorm 1367264).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.